Proteonomix has established a new subsidiary THOR BioPharma, a Nevada Corporation, to enter into Bio Pharmaceutical market.
Subscribe to our email newsletter
Proteonomix is a biotechnology company engaged in developing therapeutics based upon the use of human cells and their derivatives.
Proteonomix further intends to use THOR BioPharma to serve as the platform for technology for its Pharmaceutical business.
Intially, THOR BioPharma will focus on licensing and developing therapeutic agents for critically ill patients.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.